Gamida Cell Company

Gamida Cell is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regenerative power of therapeutic stem cells. Gamida Cell is a leader in the development of stem cell therapy technologies and products. The therapies are based on expanded populations of cord blood stem cells, for the treatment of illnesses with significant unmet clinical needs such as blood cancers, autoimmune and metabolic diseases as well as neutropenia.
Technology: Cell Therapy
Industry: Biotechnology
Headquarters: Jerusalem, Israel
Founded Date: 01.01.1998
Employees Number: 101-250
Funding Status: IPO
Investors Number: 14
Total Funding: 267 753 823
Estimated Revenue: $10M to $50M
Last Funding Date: 16.02.2021
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership